S
SteveK
Just some recent experience I thought I would share relating to a NB review of a Technical File for continuing CE certification (not actually a humidifier ? this is just an example I used previously in the post referenced). I had the following NC and Observation raised. Note that I had to close-out the Observation as if it were in fact a NC. I am also the sole TF author and only QA person.
Now I?m a bit long in the tooth now and have the experience indicated. So how other SMEs manage; with possibly limited experience and personnel in these areas, with respect to putting together these Technical File sections (and other parts) I do not know.
Non-Conformance
?Please provide the information on the personnel involved in the generation of the Risk management report and their experience with these devices and any training or experience in ISO 14971.?
I added a file note (below) to my Risk Management (RM) section to meet this NC ? this was accepted.
QA Manager (Joe Bloggs, BA Hons, MSc, NEBOSH Cert. ? JB)
JB has been with the company for circa ?n? years, and has developed an in depth knowledge of the company?s products, including the Humidifier unit during this time (overall circa 30 years? experience with medical devices) Experience being gained through interpretation of engineering drawings e.g. of the Humidifier/component parts (trained to BS 308 standards, 10+ years practice in interpreting and approving drawings for medical device tooling in the Pharma industry). Also JB has gained knowledge of the device through preparation of Works Instructions, IFU, detailed Maintenance & Service Operation Instructions, Servicing Schedules, complaints analysis, risk assessment and usability analysis. Experience in ISO 14971 is through self-training and experience of utilising the standard in the preparation and constant review and updating of ?n? Technical Files, including their Risk Management Files. JB has also had formal training in conducting Product and Process FMEAs and Value Engineering/Value Analysis.
I also added the experience of people involved in the design of the product and their input to the RM.
Observation
?Please also provide information on the experience and knowledge of the author of the clinical evaluation.?
In my literature critique section of my Clinical Evaluation (see my previous example http://elsmar.com/Forums/attachment.php?attachmentid=13006&d=1280484501) I have now modified it to add a section b - again this was accepted.
b. Analysis of and references to the literature
An extensive review of available literature has been conducted. All possible web based sources have been used, including specific medical related databases such as Medline, Cochrane Collaboration, Pubmed etc. Adverse incident sources were also utilised, including FDA?s MAUDE and other regulatory sites/databases i.e. MHRA, Afssaps, bfarm, Salute, TGA etc. Apart from incident reports, other actual primary sources could be in the form of text books, published journal papers/abstracts, patents, competitor literature, articles from healthcare publications (e.g. Nursing Times), healthcare, university and related organisations? literature (e.g. WHO) etc. The limitation of data or information referenced being not using anecdotal evidence, hearsay and similar unreliable/unprofessional sources. The ultimate judgement on the suitability or otherwise of the literature is made by a published scientific professional with experience of medical devices (including evaluating associated data and literature) from class I to class III types (from a respiratory spacer to an arterial prosthesis), covering a period of 30+ years. Key words used for the search; used singly or in Boolean logic combination, included but were not exclusively limited to: humidifier, bubble, water, bottle, breathing, diffuser, sinter, respiratory care, medical, flowmeter, oxygen, pop-off valve, ISO 8185, 35113 (GMDN), BTT (MAUDE reference code) and competitor names.
Basically I used the guidance in MEDDEV. 2.7.1 Rev.3 (Methods section) as a catch all.
Hopefully this information may be of help to someone out there.
Steve
Now I?m a bit long in the tooth now and have the experience indicated. So how other SMEs manage; with possibly limited experience and personnel in these areas, with respect to putting together these Technical File sections (and other parts) I do not know.
Non-Conformance
?Please provide the information on the personnel involved in the generation of the Risk management report and their experience with these devices and any training or experience in ISO 14971.?
I added a file note (below) to my Risk Management (RM) section to meet this NC ? this was accepted.
QA Manager (Joe Bloggs, BA Hons, MSc, NEBOSH Cert. ? JB)
JB has been with the company for circa ?n? years, and has developed an in depth knowledge of the company?s products, including the Humidifier unit during this time (overall circa 30 years? experience with medical devices) Experience being gained through interpretation of engineering drawings e.g. of the Humidifier/component parts (trained to BS 308 standards, 10+ years practice in interpreting and approving drawings for medical device tooling in the Pharma industry). Also JB has gained knowledge of the device through preparation of Works Instructions, IFU, detailed Maintenance & Service Operation Instructions, Servicing Schedules, complaints analysis, risk assessment and usability analysis. Experience in ISO 14971 is through self-training and experience of utilising the standard in the preparation and constant review and updating of ?n? Technical Files, including their Risk Management Files. JB has also had formal training in conducting Product and Process FMEAs and Value Engineering/Value Analysis.
I also added the experience of people involved in the design of the product and their input to the RM.
Observation
?Please also provide information on the experience and knowledge of the author of the clinical evaluation.?
In my literature critique section of my Clinical Evaluation (see my previous example http://elsmar.com/Forums/attachment.php?attachmentid=13006&d=1280484501) I have now modified it to add a section b - again this was accepted.
b. Analysis of and references to the literature
An extensive review of available literature has been conducted. All possible web based sources have been used, including specific medical related databases such as Medline, Cochrane Collaboration, Pubmed etc. Adverse incident sources were also utilised, including FDA?s MAUDE and other regulatory sites/databases i.e. MHRA, Afssaps, bfarm, Salute, TGA etc. Apart from incident reports, other actual primary sources could be in the form of text books, published journal papers/abstracts, patents, competitor literature, articles from healthcare publications (e.g. Nursing Times), healthcare, university and related organisations? literature (e.g. WHO) etc. The limitation of data or information referenced being not using anecdotal evidence, hearsay and similar unreliable/unprofessional sources. The ultimate judgement on the suitability or otherwise of the literature is made by a published scientific professional with experience of medical devices (including evaluating associated data and literature) from class I to class III types (from a respiratory spacer to an arterial prosthesis), covering a period of 30+ years. Key words used for the search; used singly or in Boolean logic combination, included but were not exclusively limited to: humidifier, bubble, water, bottle, breathing, diffuser, sinter, respiratory care, medical, flowmeter, oxygen, pop-off valve, ISO 8185, 35113 (GMDN), BTT (MAUDE reference code) and competitor names.
Basically I used the guidance in MEDDEV. 2.7.1 Rev.3 (Methods section) as a catch all.
Hopefully this information may be of help to someone out there.
Steve